Edition:
United Kingdom

Synergy Pharmaceuticals Inc (SGYP.OQ)

SGYP.OQ on NASDAQ Stock Exchange Global Select Market

2.01USD
15 Dec 2017
Change (% chg)

$0.08 (+4.15%)
Prev Close
$1.93
Open
$1.95
Day's High
$2.10
Day's Low
$1.92
Volume
11,497,892
Avg. Vol
1,103,316
52-wk High
$7.15
52-wk Low
$1.68

Chart for

About

Synergy Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of gastrointestinal (GI) therapies. The Company's product candidates include TRULANCE (plecanatide) and dolcanatide. The Company is engaged in the discovery, research and development efforts around analogs of uroguanylin... (more)

Overall

Beta: 1.31
Market Cap(Mil.): $778.34
Shares Outstanding(Mil.): 224.95
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-CVI Investments reports a 7.9 pct passive stake in Synergy Pharmaceuticals as of Nov 13, 2017

* CVI Investments Inc reports a 7.9 percent passive stake in Synergy Pharmaceuticals Inc as of November 13, 2017 - SEC Filing‍​ Source text: (http://bit.ly/2A4qbNI) Further company coverage:

22 Nov 2017

BRIEF-Synergy Pharma announces pricing of offering of common stock and warrants

* Synergy Pharmaceuticals announces pricing of offering of common stock and warrants

13 Nov 2017

BRIEF-Synergy Pharma files for a potential mixed shelf offering ‍​

* Synergy Pharmaceuticals Inc files for a potential mixed shelf offering; size undisclosed - SEC filing ‍​ Source text: (http://bit.ly/2mihpZ2) Further company coverage:

13 Nov 2017

BRIEF-Synergy Pharmaceuticals posts Q3 loss per share $0.22

* Synergy Pharmaceuticals reports third quarter 2017 financial results and business update

09 Nov 2017

BRIEF-Synergy Pharmaceuticals secures $300 mln debt financing

* Synergy Pharmaceuticals secures $300 million debt financing

05 Sep 2017

BRIEF-Synergy Pharma Q2 sales $2.3 million

* Synergy Pharmaceuticals reports second quarter 2017 financial results and business update

09 Aug 2017

Earnings vs. Estimates